A Comparative Study on Interactions and Influence of Alkalizers on Dissolution Rate of Telmisartan

Download PDF

For preformulation studies in formulation development, compatibility studies are crucial. Telmisartan is an angiotensin II receptor blocker [ABRs]. It is also used in the treatment of heart attack and stroke. It is a BCS class II drug. Since telmisartan's solubility is pH-dependent, a few alkalizing agents are utilized to speed up the solubility and dissolution process. The objective of this study was to enhance the solubility of telmisartan. Alkalizing agents such as magnesium hydroxide, sodium bicarbonate, aluminium hydroxide, and barium carbonate are used. Telmisartan solid dispersions with the selected alkalizing agents were formulated by employing a kneading technique and subjected to IR spectral, HPLC, and in vitro dissolution studies. Magnesium hydroxide was found to be preferable compared to other alkalizers based on docking, IR spectral, and HPLC techniques and in vitro dissolution studies. The results demonstrated the enhanced solubility of telmisartan with magnesium hydroxide and sodium lauryl sulphate at ratios. This study concluded that the addition of an alkalizing agent like magnesium hydroxide improves the solubility of class–II drugs.